{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:10:39Z","timestamp":1792804239913,"version":"4.5.0"},"reference-count":51,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2024,5,14]]},"abstract":"<jats:p>Background: Behavioral and psychological symptoms of dementia (BPSD) and prescribed central nervous system (CNS) active drugs to treat them are prevalent among persons living with Alzheimer\u2019s disease and related dementias (PLWD) and lead to negative outcomes for PLWD and their caregivers. Yet, little is known about racial\/ethnic disparities in diagnosis and use of drugs to treat BPSD. Objective: Quantify racial\/ethnic disparities in BPSD diagnoses and CNS-active drug use among community-dwelling PLWD. Methods: We used a retrospective cohort of community-dwelling Medicare Fee-for-Service beneficiaries with dementia, continuously enrolled in Parts A, B and D, 2017\u20132019. Multivariate logistic models estimated rates of BPSD diagnosis and, conditional on diagnosis, CNS-active drug use. Results: Among PLWD, 67.1% had diagnoses of an affective, psychosis or hyperactivity symptom. White (68.3%) and Hispanic (63.9%) PLWD were most likely, Blacks (56.6%) and Asians (52.7%) least likely, to have diagnoses. Among PLWD with BPSD diagnoses, 78.6% took a CNS-active drug. Use was highest among whites (79.3%) and Hispanics (76.2%) and lowest among Blacks (70.8%) and Asians (69.3%). Racial\/ethnic differences in affective disorders were pronounced, 56.8% of white PLWD diagnosed; Asians had the lowest rates (37.8%). Similar differences were found in use of antidepressants. Conclusions: BPSD diagnoses and CNS-active drug use were common in our study. Lower rates of BPSD diagnoses in non-white compared to white populations may indicate underdiagnosis in clinical settings of treatable conditions. Clinicians\u2019 review of prescriptions in this population to reduce poor outcomes is important as is informing care partners on the risks\/benefits of using CNS-active drugs.<\/jats:p>","DOI":"10.3233\/jad-231266","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T14:03:59Z","timestamp":1714140239000},"page":"513-523","source":"Crossref","is-referenced-by-count":13,"title":["Diagnoses and Treatment of Behavioral and Psychological Symptoms of Dementia Among Racially and Ethnically Diverse Persons Living with Dementia"],"prefix":"10.1177","volume":"99","author":[{"given":"Johanna A.","family":"Thunell","sequence":"first","affiliation":[{"name":"USC Schaeffer Center for Health Policy and Economics, Los Angeles, CA, USA"},{"name":"USC Sol Price School of Public Policy, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey F.","family":"Joyce","sequence":"additional","affiliation":[{"name":"USC Schaeffer Center for Health Policy and Economics, Los Angeles, CA, USA"},{"name":"USC School of Pharmacy, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia M.","family":"Ferido","sequence":"additional","affiliation":[{"name":"USC Schaeffer Center for Health Policy and Economics, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Chen","sequence":"additional","affiliation":[{"name":"Rush Alzheimer\u2019s Disease Center, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny S.","family":"Guadamuz","sequence":"additional","affiliation":[{"name":"USC Schaeffer Center for Health Policy and Economics, Los Angeles, CA, USA"},{"name":"USC School of Pharmacy, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dima M.","family":"Qato","sequence":"additional","affiliation":[{"name":"USC Schaeffer Center for Health Policy and Economics, Los Angeles, CA, USA"},{"name":"USC School of Pharmacy, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Zissimopoulos","sequence":"additional","affiliation":[{"name":"USC Schaeffer Center for Health Policy and Economics, Los Angeles, CA, USA"},{"name":"USC Sol Price School of Public Policy, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-231266_ref1","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3233\/JAD-215198","article-title":"Behavioral and psychological symptoms of dementia in different dementia disorders: A large-scale study of 10,000 individuals","volume":"87","author":"Schwertner","year":"2022","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.3233\/JAD-231266_ref2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/gps.2550","article-title":"Neuropsychiatric symptoms and quality of life in patients with very mild and mild Alzheimer\u2019s disease","volume":"26","author":"Karttunen","year":"2011","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JAD-231266_ref3","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jagp.2013.12.175","article-title":"A multidimensional home-based care coordination intervention for elders with memory disorders: The maximizing independence at home (MIND) pilot randomized trial","volume":"22","author":"Samus","year":"2014","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3233\/JAD-231266_ref4","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1176\/appi.ajp.20220508","article-title":"Dementia is more than memory loss: Neuropsychiatric symptoms of dementia and their nonpharmacological and pharmacological management","volume":"179","author":"Tampi","year":"2022","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3233\/JAD-231266_ref5","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.jamda.2019.03.027","article-title":"Impact of cognitive, functional, behavioral disorders, and caregiver burden on the risk of nursing home placement","volume":"20","author":"Dufournet","year":"2019","journal-title":"J Am Med Dir Assoc"},{"key":"10.3233\/JAD-231266_ref6","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1001\/jama.287.16.2090","article-title":"Patient and caregiver characteristics and nursing home placement in patients with dementia","volume":"287","author":"Yaffe","year":"2002","journal-title":"JAMA"},{"key":"10.3233\/JAD-231266_ref7","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/gps.4599","article-title":"Management of older adults with dementia who present to emergency services with neuropsychiatric symptoms","volume":"32","author":"Silwanowicz","year":"2017","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JAD-231266_ref8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1192\/bjp.bp.113.137166","article-title":"Prediction of general hospital admission in people with dementia: Cohort study","volume":"206","author":"Russ","year":"2015","journal-title":"Br J Psychiatry"},{"key":"10.3233\/JAD-231266_ref9","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1080\/13607863.2020.1727848","article-title":"Mortality in patients with behavioural and psychological symptoms of dementia: A registry-based study","volume":"25","author":"Br\u00e4nsvik","year":"2021","journal-title":"Aging Ment Health"},{"key":"10.3233\/JAD-231266_ref10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/gps.490","article-title":"The cost of behavioral and psychological symptoms of dementia (BPSD) in community dwelling Alzheimer\u2019s disease patients","volume":"17","author":"Schnaider Beeri","year":"2002","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JAD-231266_ref11","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/jgs.12210","article-title":"Pharmacotherapeutic management of dementia across settings of care","volume":"61","author":"Rattinger","year":"2013","journal-title":"J Am Geriatr Soc"},{"key":"10.3233\/JAD-231266_ref12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/jgs.18119","article-title":"Antiepileptic prescribing to persons living with dementia residing in nursing homes: A tale of two indications","volume":"71","author":"Candon","year":"2022","journal-title":"J Am Geriatr Soc"},{"key":"10.3233\/JAD-231266_ref13","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1001\/jama.293.5.596","article-title":"Pharmacological treatment of neuropsychiatric symptoms of dementia: A review of the evidence","volume":"293","author":"[13] Sink","year":"2005","journal-title":"JAMA"},{"key":"10.3233\/JAD-231266_ref14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/bmj.38125.465579.55","article-title":"Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: Systematic review","volume":"329","author":"Lee","year":"2004","journal-title":"BMJ"},{"key":"10.3233\/JAD-231266_ref15","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/jama.2020.8519","article-title":"Prevalence of psychotropic and opioid prescription fills among community-dwelling older adults with dementia in the US","volume":"324","author":"Maust","year":"2020","journal-title":"JAMA"},{"key":"10.3233\/JAD-231266_ref16","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s40801-021-00265-4","article-title":"Potentially inappropriate medication use in older adults with Alzheimer\u2019s disease and related dementias living in the community: A cross-sectional analysis","volume":"8","author":"Vickers","year":"2021","journal-title":"Drugs Real World Outcomes"},{"key":"10.3233\/JAD-231266_ref17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4321\/S1886-36552007000300008","article-title":"Psychotropic and psychoactive drugs and hospitalization rates in nursing facility residents","volume":"5","author":"Cooper","year":"2007","journal-title":"Pharm Pract (Granada)"},{"key":"10.3233\/JAD-231266_ref18","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/gps.4483","article-title":"Psychotropic drugs and the risk of fall injuries, hospitalisations and mortality among older adults","volume":"32","author":"Johnell","year":"2017","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JAD-231266_ref19","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s40266-015-0287-4","article-title":"Impact of inappropriate drug use on hospitalizations, mortality, and costs in older persons and persons with dementia: Findings from the SNAC study","volume":"32","author":"Sk\u00f6ldunger","year":"2015","journal-title":"Drugs Aging"},{"key":"10.3233\/JAD-231266_ref20","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1001\/jamapsychiatry.2014.3018","article-title":"Antipsychotics, other psychotropics, and the risk of death in patients with dementia: Number needed to harm","volume":"72","author":"Maust","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.3233\/JAD-231266_ref21","doi-asserted-by":"crossref","first-page":"e190828","DOI":"10.1001\/jamanetworkopen.2019.0828","article-title":"Assessment of reported comparative effectiveness and safety of atypical antipsychotics in the treatment of behavioral and psychological symptoms of dementia: A network meta-analysis","volume":"2","author":"Yunusa","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.3233\/JAD-231266_ref22","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/gps.4452","article-title":"Psychotropic use and associated neuropsychiatric symptoms among patients with dementia in the USA","volume":"32","author":"Maust","year":"2017","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JAD-231266_ref23","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1093\/gerona\/glz045","article-title":"Association between antipsychotics and all-cause mortality among community-dwelling older adults","volume":"74","author":"Kheirbek","year":"2019","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.3233\/JAD-231266_ref24","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa052827","article-title":"Risk of death in elderly users of conventional vs. atypical antipsychotic medications","volume":"353","author":"Wang","year":"2005","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-231266_ref25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1176\/appi.ajp.2011.11030347","article-title":"Risk of mortality among individual antipsychotics in patients with dementia","volume":"169","author":"Kales","year":"2012","journal-title":"Am J Psychiatry"},{"key":"10.3233\/JAD-231266_ref26","first-page":"695","article-title":"Fall and fracture risk in nursing home residents with moderate-to-severe behavioral symptoms of Alzheimer\u2019s disease and related dementias initiating antidepressants or antipsychotics","volume":"72","author":"Wei","year":"2017","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.3233\/JAD-231266_ref27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3233\/JAD-190310","article-title":"Measuring Alzheimer\u2019s disease and other dementias in diverse populations using medicare claims data","volume":"72","author":"Thunell","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-231266_ref28","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.jalz.2019.07.005","article-title":"Longitudinal analysis of dementia diagnosis and specialty care among racially diverse Medicare beneficiaries","volume":"15","author":"Drabo","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-231266_ref29","first-page":"100179","article-title":"Racial\/ethnic disparities in length of life after dementia diagnosis: An 18-year follow-up study of Medicare beneficiaries","volume":"8","author":"Chen","year":"2022","journal-title":"Lancet Reg Health Am"},{"key":"10.3233\/JAD-231266_ref30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/016128400248284","article-title":"The biological basis of behavioral symptoms in dementia","volume":"21","author":"Garand","year":"2000","journal-title":"Issues Ment Health Nurs"},{"key":"10.3233\/JAD-231266_ref31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fneur.2012.00073","article-title":"Behavioral and psychological symptoms of dementia","volume":"3","author":"Cerejeira","year":"2012","journal-title":"Front Neurol"},{"key":"10.3233\/JAD-231266_ref32","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/jpm10030090","article-title":"Behavioral and psychological symptoms of dementia (BPSD): Clinical characterization and genetic correlates in an Italian Alzheimer\u2019s disease cohort","volume":"10","author":"Scassellati","year":"2020","journal-title":"J Pers Med"},{"key":"10.3233\/JAD-231266_ref33","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1097\/00002093-200200002-00005","article-title":"The cultural influence of values, norms, meanings, and perceptions in understanding dementia in ethnic minorities","volume":"16","author":"Dilworth-Anderson","year":"2002","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-231266_ref34","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1177\/1471301218788147","article-title":"Associations of knowledge of Alzheimer\u2019s disease and memory loss and employment status with burden in African American and Caucasian family caregivers","volume":"19","author":"Scott","year":"2020","journal-title":"Dementia"},{"key":"10.3233\/JAD-231266_ref35","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/WAD.0b013e3181a6bc21","article-title":"Making sense of behavioral disturbances in persons with dementia: Latino family caregiver attributions of neuropsychiatric inventory domains","volume":"23","author":"Hinton","year":"2009","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-231266_ref36","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/01634372.2015.1005785","article-title":"Assessment of Alzheimer\u2019s disease symptom recognition in Korean Americans and psychometric analysis of Alzheimer\u2019s Disease Symptom Recognition Scale (ADSRS)","volume":"58","author":"Lee","year":"2015","journal-title":"J Gerontol Soc Work"},{"key":"10.3233\/JAD-231266_ref37","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1377\/hlthaff.27.2.393","article-title":"New evidence regarding racial and ethnic disparities in mental health: Policy implications","volume":"27","author":"McGuire","year":"2008","journal-title":"Health Aff (Millwood)"},{"key":"10.3233\/JAD-231266_ref38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6963-7-202","article-title":"Validation of a method for identifying nursing home admissions using administrative claims","volume":"7","author":"Zuckerman","year":"2007","journal-title":"BMC Health Serv Res"},{"key":"10.3233\/JAD-231266_ref39","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1001\/jamapsychiatry.2017.0660","article-title":"Trajectories of depressive symptoms before diagnosis of dementia: A 28-year follow-up study","volume":"74","author":"Singh-Manoux","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.3233\/JAD-231266_ref40","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.jagp.2018.08.012","article-title":"High occurrence of psychiatric disorders and suicidal behavior across dementia subtypes","volume":"26","author":"Lai","year":"2018","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3233\/JAD-231266_ref42","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/gps.4037","article-title":"Grouping of behavioural and psychological symptoms of dementia","volume":"29","author":"van der Linde","year":"2014","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JAD-231266_ref43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.31887\/DCNS.2008.10.1\/hcrgrunze","article-title":"The effectiveness of anticonvulsants in psychiatric disorders","volume":"10","author":"Grunze","year":"2022","journal-title":"Dialogues Clin Neurosci"},{"key":"10.3233\/JAD-231266_ref44","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3233\/JAD-190787","article-title":"The use of opioids and antipsychotics in elderly with dementia\u2013have opioids replaced antipsychotics in treating behavioral symptoms in dementia?","volume":"73","author":"Jensen-Dahm","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-231266_ref46","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"10.3233\/JAD-231266_ref47","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000351009","article-title":"Risk factors for behavioral abnormalities in mild cognitive impairment and mild Alzheimer\u2019s disease","volume":"37","author":"Apostolova","year":"2014","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-231266_ref48","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/j.1532-5415.2004.52356.x","article-title":"Ethnic differences in the prevalence and pattern of dementia-related behaviors","volume":"52","author":"Sink","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"10.3233\/JAD-231266_ref49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1176\/appi.neuropsych.15120423","article-title":"Cross-ethnic differences in the severity of neuropsychiatric symptoms in persons with mild cognitive impairment and Alzheimer\u2019s disease","volume":"29","author":"Salazar","year":"2017","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.3233\/JAD-231266_ref50","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1176\/jnp.15.3.346","article-title":"Psychiatric symptoms vary with the severity of dementia in probable Alzheimer\u2019s disease","volume":"15","author":"Lopez","year":"2003","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.3233\/JAD-231266_ref51","doi-asserted-by":"crossref","first-page":"h369","DOI":"10.1136\/bmj.h369","article-title":"Assessment and management of behavioral and psychological symptoms of dementia","volume":"350","author":"Kales","year":"2015","journal-title":"BMJ"},{"key":"10.3233\/JAD-231266_ref52","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1176\/appi.ajp.2015.173501","article-title":"The American Psychiatric Association practice guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia","volume":"173","author":"Reus","year":"2016","journal-title":"Am J Psychiatry"},{"key":"10.3233\/JAD-231266_ref53","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1001\/jama.2021.1195","article-title":"Prevalence of central nervous system\u2013active polypharmacy among older adults with dementia in the US","volume":"325","author":"Maust","year":"2021","journal-title":"JAMA"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-231266","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:08:33Z","timestamp":1777370913000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-231266"}},"subtitle":[],"editor":[{"given":"Brian","family":"Downer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,5,14]]},"references-count":51,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-231266","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,14]]}}}